Lantheus Holdings, Inc. and Corcept Therapeutics Incorporated: A Detailed Gross Profit Analysis

Healthcare Giants' Gross Profit Surge: 2014-2023

__timestampCorcept Therapeutics IncorporatedLantheus Holdings, Inc.
Wednesday, January 1, 201425669000125519000
Thursday, January 1, 201548925000135522000
Friday, January 1, 201679263000137780000
Sunday, January 1, 2017155647000162135000
Monday, January 1, 2018246032000174885000
Tuesday, January 1, 2019300982000174811000
Wednesday, January 1, 2020348292000138761000
Friday, January 1, 2021360697000187695000
Saturday, January 1, 2022396473000581703000
Sunday, January 1, 2023475894000709543000
Loading chart...

Unveiling the hidden dimensions of data

A Tale of Two Companies: Gross Profit Growth from 2014 to 2023

In the competitive landscape of the healthcare sector, Lantheus Holdings, Inc. and Corcept Therapeutics Incorporated have demonstrated remarkable growth in gross profit over the past decade. From 2014 to 2023, Corcept Therapeutics saw its gross profit skyrocket by approximately 1,750%, starting from a modest 26 million in 2014 to an impressive 476 million in 2023. Meanwhile, Lantheus Holdings experienced a substantial increase of around 465%, with gross profits rising from 126 million to 710 million during the same period.

Key Insights

  • Corcept Therapeutics: The company showed consistent growth, with a notable surge in 2017, doubling its gross profit from the previous year.
  • Lantheus Holdings: A significant leap occurred in 2022, with gross profits increasing by over 200% compared to 2021.

These trends highlight the dynamic nature of the healthcare industry and the potential for substantial financial growth.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025